BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | – | 42,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 200,049 | $1,976,000 | 0.04% |
| Q Global Advisors, LLC | 195,694 | $45,000 | 0.03% |
| Telemetry Investments, L.L.C. | 33,303 | $7,000 | 0.01% |
| FIFTH LANE CAPITAL, LP | 51,250 | $12,000 | 0.01% |
| MARSHALL WACE, LLP | 190,150 | $1,879,000 | 0.00% |
| CANTOR FITZGERALD, L. P. | 250,000 | $58,000 | 0.00% |
| MMCAP International Inc. SPC | 325,000 | $75,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 650,866 | $150,000 | 0.00% |
| Context Capital Management, LLC | 105,069 | $24,000 | 0.00% |
| COWEN AND COMPANY, LLC | 94,785 | $22,000 | 0.00% |